Advertisement

Topics

Search Results for "London Diabetes Conference Mar 2012"

10:03 EDT 29th April 2016 | BioPortfolio

Matching Channels

Matching News

#jobs #lifescience SMi’s 3rd annual conference – Immunogenicity, London, UK

// Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due The post SMi’s 3rd annual conference – Immunogenicity...

Are new diabetes drugs approved too easily?

Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar? In this...

SynBioBeta is Connecting the Global Synthetic Biology Industry at their 4th Annual London Conference

On April 6th - 8th, SynBioBeta with support of event host SynbiCITE, will once again bring together the synthetic biology community for the fourth annual SynBioBeta London 2016 Conference at Impe...

David Johnson’s New Book Offers Hope for Those with Diabetes

LONDON, Ala. (PRWEB) October 22, 2015 When author David Johnson was diagnosed with type 2 diabetes , he knew he wasn’t going...

HDMA to hold annual conference in London

David SalazarHDMA’s Third Annual International Pharmaceutical Distribution Conference will take place in London from Sept. 12-13 and it is co-hosted with various European  healthcare distri...

One in Two Mexicans Could Have Diabetes by 2050

A modeling study projects that one in two Mexicans could have diabetes by 2050; diabetes diagnoses in Mexican adults skyrocketed by 30% from 2000 to 2012. Medscape Medical News

[Comment] Trends in diabetes: sounding the alarm

Diabetes is a major cause of death and disability worldwide. In 2012 it caused as many deaths as HIV/AIDS (1·5 million).1 Disability resulting from diabetes has grown substantially since 1990, with p...

London 2012 partner, GlaxoSmithKline, shares scientific expertise with World Anti-Doping Agency to help fight against abuse of drugs in sport

London 2012 partner GlaxoSmithKline (GSK) today signed a long-term agreement with the World Anti-Doping Agency (WADA) that will help the agency create early detection methods for medicines that have p...

Matching PubMed Articles

Abstracts from ATTD 2016 9th International Conference on Advanced Technologies & Treatments for Diabetes Milan, Italy-February 3-6, 2016.

Abstracts from ATTD 2015 8th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France-February 18-21, 2015.

ConsEuro Conference 2015, London, May 14-16.

Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012).

Type 2 Diabetes (T2DM) is the most rapidly increasing risk factor for ischemic stroke. We aimed to compare trends in outcomes for ischemic stroke in people with or without diabetes in Spain between 20...

Quality of Type II Diabetes Care in Primary Health Care Centers in Kuwait: Employment of a Diabetes Quality Indicator Set (DQIS).

Diabetes Mellitus is one of the major public health challenges, affecting more than 347 million adults worldwide. The impact of diabetes necessitates assessing the quality of care received by people w...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement